FI834147A - 6,7-dihydro-5,8-dimetyl-9-fluoro-1-oxo-1h,5h-benzo ij/kinolizin-2-karboxyl-syra och derivat - Google Patents

6,7-dihydro-5,8-dimetyl-9-fluoro-1-oxo-1h,5h-benzo ij/kinolizin-2-karboxyl-syra och derivat Download PDF

Info

Publication number
FI834147A
FI834147A FI834147A FI834147A FI834147A FI 834147 A FI834147 A FI 834147A FI 834147 A FI834147 A FI 834147A FI 834147 A FI834147 A FI 834147A FI 834147 A FI834147 A FI 834147A
Authority
FI
Finland
Prior art keywords
quinolizine
benzo
dihydro
oxo
fluoro
Prior art date
Application number
FI834147A
Other languages
English (en)
Other versions
FI834147A0 (fi
FI73213B (fi
FI73213C (fi
Inventor
Richard Mark Stern
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of FI834147A0 publication Critical patent/FI834147A0/fi
Publication of FI834147A publication Critical patent/FI834147A/fi
Publication of FI73213B publication Critical patent/FI73213B/fi
Application granted granted Critical
Publication of FI73213C publication Critical patent/FI73213C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
FI834147A 1982-11-12 1983-11-11 Foerfarande foer framstaellning av 6,7-dihydro-5,8-dimetyl-9-fluor-1-oxo-1h,5h-benzo/i,j/kinolizin-2 -karboxyl-syra och mellanprodukter foer anvaendning vid foerfarandet. FI73213C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/441,245 US4472405A (en) 1982-11-12 1982-11-12 Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives
US44124582 1982-11-12

Publications (4)

Publication Number Publication Date
FI834147A0 FI834147A0 (fi) 1983-11-11
FI834147A true FI834147A (fi) 1984-05-13
FI73213B FI73213B (fi) 1987-05-29
FI73213C FI73213C (fi) 1987-09-10

Family

ID=23752110

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834147A FI73213C (fi) 1982-11-12 1983-11-11 Foerfarande foer framstaellning av 6,7-dihydro-5,8-dimetyl-9-fluor-1-oxo-1h,5h-benzo/i,j/kinolizin-2 -karboxyl-syra och mellanprodukter foer anvaendning vid foerfarandet.

Country Status (22)

Country Link
US (1) US4472405A (fi)
EP (1) EP0109284B1 (fi)
JP (1) JPH0826017B2 (fi)
KR (1) KR890000864B1 (fi)
AT (1) ATE39926T1 (fi)
AU (1) AU568319B2 (fi)
CA (2) CA1254568A (fi)
CS (1) CS390391A3 (fi)
DE (1) DE3378912D1 (fi)
EG (1) EG16492A (fi)
ES (1) ES8504727A1 (fi)
FI (1) FI73213C (fi)
GR (1) GR79402B (fi)
IE (1) IE56232B1 (fi)
IL (1) IL70198A (fi)
IN (1) IN161391B (fi)
MX (1) MX7314E (fi)
NO (1) NO160782C (fi)
NZ (1) NZ206233A (fi)
OA (1) OA07586A (fi)
PT (1) PT77649B (fi)
ZA (1) ZA838436B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519926A1 (de) * 1985-06-04 1986-12-04 Bayer Ag Indolinderivate, verfahren zu ihrer herstellung und diese indolinderivate enthaltende kosmetische lichtschutzmittel
US4898945A (en) * 1986-01-22 1990-02-06 Minnesota Mining And Manufacturing Company Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid
CA1302413C (en) * 1986-01-22 1992-06-02 Bruce E. Williams Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo- 1h,5h-benzo[ij]quinolizine-2-carboxylic acid
GB9827865D0 (en) * 1998-12-18 1999-02-10 Woodcock Fiona Medicament
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
CA2814082A1 (en) 2010-10-12 2012-04-19 Bayer Intellectual Property Gmbh Non-starch based soft chewables
UA118748C2 (uk) 2012-12-19 2019-03-11 Байєр Енімал Хелс Гмбх Таблетки, що мають покращене сприйняття та хорошу стабільність при зберіганні
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
EP4025220A4 (en) * 2019-09-06 2023-10-04 Elanco US Inc. TASTY VETERINARY MEDICINAL COMPOSITIONS IN GRANULE FORM

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA728444B (en) * 1971-12-30 1973-10-31 Riker Laboratories Inc Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof
BE793524A (fr) * 1971-12-30 1973-06-29 Riker Laboratories Inc Acides benzoquinolizine-carboxyliques et leurs derives
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
JPS5655388A (en) 1979-10-11 1981-05-15 Otsuka Pharmaceut Co Ltd Benzo ij quinolidine-2-carboxylic acid derivative, and its preparation
US4301289A (en) * 1980-02-19 1981-11-17 Minnesota Mining And Manufacturing Company Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid
JPS59155381A (ja) * 1983-02-22 1984-09-04 Kyorin Pharmaceut Co Ltd ベンゾキノリジンカルボン酸誘導体及びその製造法

Also Published As

Publication number Publication date
NZ206233A (en) 1986-10-08
CA1254568A (en) 1989-05-23
FI834147A0 (fi) 1983-11-11
ES527163A0 (es) 1985-05-01
DE3378912D1 (de) 1989-02-16
IL70198A0 (en) 1984-02-29
AU2118183A (en) 1984-05-17
EG16492A (en) 1994-11-30
FI73213B (fi) 1987-05-29
IE56232B1 (en) 1991-05-22
KR890000864B1 (ko) 1989-04-11
FI73213C (fi) 1987-09-10
EP0109284A1 (en) 1984-05-23
EP0109284B1 (en) 1989-01-11
IE832639L (en) 1984-05-12
MX7314E (es) 1988-05-11
IL70198A (en) 1988-11-15
IN161391B (fi) 1987-11-28
ATE39926T1 (de) 1989-01-15
PT77649B (en) 1986-03-19
PT77649A (en) 1983-12-01
KR840006659A (ko) 1984-12-01
NO834093L (no) 1984-05-14
NO160782C (no) 1989-05-31
NO160782B (no) 1989-02-20
ZA838436B (en) 1985-06-26
US4472405A (en) 1984-09-18
GR79402B (fi) 1984-10-22
JPH0826017B2 (ja) 1996-03-13
OA07586A (fr) 1985-03-31
AU568319B2 (en) 1987-12-24
CS390391A3 (en) 1992-09-16
CA1280755C (en) 1991-02-26
ES8504727A1 (es) 1985-05-01
JPS59112969A (ja) 1984-06-29

Similar Documents

Publication Publication Date Title
FI834147A (fi) 6,7-dihydro-5,8-dimetyl-9-fluoro-1-oxo-1h,5h-benzo ij/kinolizin-2-karboxyl-syra och derivat
NO173547C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater
ATE146473T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
ES8702405A1 (es) Procedimiento para la obtencion de acidos benzo(ij) quinolizina-2-carboxilicos y sus derivados
IT8048062A0 (it) Derivati di acidi mercaptoacildii dropirazol carbossilici dotati di attivita' ipotensiva e procedimento per la loro preparazione
NO173607C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive tienotriazolo-diazepin-derivater
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
JPS57108066A (en) 4-substituted-2-oxoazetidine derivative and its preparation
SE8301687L (sv) 8-cyano-6,7-dihydro-5-metyl-1-oxo-1h-,5h-benso(ij)kinolizin-2-karboxylsyror och forfarande for framstellning derav
IT7850230A0 (it) Derivati di alfa-alogenometilammino acidi ad attivita' farmaceutica eprocedimento per la loro preparazione
NO151619C (no) Fremgangsmaate for fremstilling av cyklopropan-karboksylsyreester-derivater
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater
IT8024165A0 (it) Esteri di acidi dialogenovinilciclopropancarbossili ci, procedimento per la loro preparazione e loro impiego per combattere organismi nocivi e anche alcooli alfa-alogenoetinil-3-fenossi-benzilici.
ES556137A0 (es) Un procedimiento para preparar derivados de penem
IT1101667B (it) Esteri 3-fenossi-alfa-vinil-benzilici di acidi vinil-ciclopropan-carbossilici, procedimento per la loro preparatione e loro impiego per combattere organismi nocivi
DK550183A (da) 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo/ij/-quinolizin-2-carboxylsyre, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved udoevelse af fremgangsmaaden
IT8048188A0 (it) Derivati di acido 2 idrossi 5 1 idrossi 2 4 2 osso 1 benzimidazo linil piperidino etil benzoico eprocedimento per la loro preparazione
JPS57183737A (en) Use of phenylaliphatic carboxylic acid derivative as drug
HUT60736A (en) Process for producing derivatives of 3-l-(5-thioxo-l-prolyl)-thiazolidine-4-carboxylic acid and pharmaceutical compositions comprising same as active ingredient
DE3374316D1 (en) Penicillin derivatives
ES509154A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.
IT1141197B (it) Composti farmaceuticamente attivi e procedimento per la loro produzione
IT8048484A0 (it) Derivati di alfa-alogenometilammino acidi ad attivita' farmaceutica eprocedimento per la loro preparazione
LV5479A3 (lv) Hinolina atvasinajumu vai to farmaceitiski pienemamu esteru vai farmaceitiski pienemamu skabes aditivo salu iegusanas metode
NO158217C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive ester-derivater av acetylsalicylsyre.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: RIKER LABORATORIES, INC.